The alternative text for this image may have been generated using AI. Because these chromatin marks seem to be maintained differentially on essentially identical alleles over many cell generations, it ...
c.156_157insAlu is a founder mutation of Portuguese origin and is the most frequent BRCA2 rearrangement described to date.
Recently, the team led by Academician Wei-Hong Zhu at East China University of Science and Technology proposed a novel photo-rearrangement reaction of diarylethenes induced by intramolecular proton ...
Duplications and deletions in the human genome can cause disease or predispose persons to disease. Advances in technologies to detect these changes allow for the routine identification of ...
The FDA Friday approved pemigatinib (Pemazyre), a selective fibroblast growth factor (FGFR) inhibitor, to treat adults who have relapsed or refractory (R/R) myeloid/lymphoid neoplasms (MLNs) with ...
The Jingjing Wu group at the National Key Laboratory of Synergistic Materials Creation/Frontier Science Center for Transformative Molecules (FSCTM) at Shanghai Jiao Tong University, in collaboration ...
Phase II trial of bortezomib in KRAS G12D mutant lung cancers. This is an ASCO Meeting Abstract from the 2015 ASCO Annual Meeting I. This abstract does not include a full text component.
Indications : The test is ordered to detect BCL2 rearrangements in B-cell lymphomas. The BCL2 rearrangement is found in follicular lymphomas, large diffuse B-cell lymphomas, and undifferentiated ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results